BIIB Colombia is a regional subsidiary of Biogen Inc., a global leader in biotechnology founded in 1978. The company focuses on developing innovative therapies for complex and devastating diseases, including neurological, neuropsychiatric, specialized immunology, and rare diseases. The website presents a professional and consistent corporate image, targeting Spanish-speaking audiences in Colombia with comprehensive information about the company, its therapeutic areas, and career opportunities. The digital infrastructure leverages Adobe Experience Manager CMS, modern JavaScript libraries, and integrates Google Analytics and Cookiebot for privacy compliance. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though some security headers and explicit incident response policies are absent. WHOIS data is redacted, a common practice for corporate domains, and does not raise immediate concerns. Overall, the site demonstrates good technical maturity, privacy compliance, and business credibility.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
83/ 100 · Low
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
2 findings rated critical or high. Fix these first.
Email security
SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.
Critical
No email authentication configured
Domain is vulnerable to email spoofing
What to do: Implement SPF, DKIM, and DMARC immediately
SSL/TLS
TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.
High
Weak Protocols Supported
Server supports weak protocols: TLSv1.1
What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions
This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
77
Security headers
95
Email security
60
DNS health
70
Network security
100
GDPR outside view
83
Average
81
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention biibcolombia.co, from OffSeq Breach.
No leaked records found
Breach holds no records for biibcolombia.co right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
The company holds a strong market position as a biotechnology leader with a focus on neurological and rare diseases. Its business model centers on pharmaceutical research and development, targeting healthcare professionals, patients, and stakeholders in Colombia. The website supports brand consistency and trust through social media integration and detailed corporate content. The absence of direct contact emails or phone numbers suggests a preference for controlled communication channels via contact forms. The extensive network of related Biogen domains globally indicates a well-established partnership and subsidiary ecosystem.
Security posture
The website enforces HTTPS and uses HttpOnly cookies to protect session data. Cookie consent is managed via Cookiebot, indicating GDPR compliance. However, the lack of visible security headers such as Content-Security-Policy or X-Frame-Options is a gap. No vulnerability disclosure or security.txt files were found, limiting transparency for security researchers. No exposed sensitive data or vulnerable libraries were detected in the HTML content. Incident response contact information is not provided, which could be improved to enhance security readiness.
Recommendations
Implement standard security headers (CSP, X-Frame-Options, X-XSS-Protection) to mitigate common web attacks.
Publish a security policy and incident response contact to improve transparency and trust.
Add a vulnerability disclosure or security.txt file to facilitate responsible reporting.
Enhance accessibility features to improve compliance and user experience for all users.
Regularly audit third-party scripts and dependencies to ensure no vulnerabilities are introduced.
Site observations
Automated reading of the public site. Ratings are indicative.
Business
Company
BIIB Colombia
Description
Biogen es una empresa líder en biotecnología a nivel global, pionera en la ciencia y que impulsa innovaciones para enfermedades complejas y devastadoras. Biogen avanza continuamente en el desarrollo de posibles terapias en neurología, neuropsiquiatría, inmunología especializada y enfermedades raras, manteniendo enfoque en su propósito de servir a la humanidad a través de la ciencia, promoviendo así un mundo más saludable, sostenible y equitativo.
Key services
development of therapies for neurological diseases, neuropsychiatry, specialized immunology, rare diseases
Content quality
good
Branding
consistent
Technology
Stack
Adobe Helix RUM, jQuery 3.6.4, Cookiebot, Google Tag Manager, Google Analytics, Video.js
Frameworks
Adobe Experience Manager (AEM)
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good
Security
Observed score
85/100
Good practices seen
HTTPS enforced
Cookie consent mechanism
HttpOnly cookies for session security
Analytics and tracking
Services
Google Analytics
Tracking level
moderate
Privacy practices
good
Advertising
Tracking pixels
Cookiebot
Transparency
good
Site quality
Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high
Key observations
Website is fully accessible with rich content in Spanish targeting Colombia.
Strong corporate branding consistent with Biogen Inc.
Comprehensive cookie consent and privacy policy mechanisms implemented.
No exposed sensitive data or obvious security issues found in HTML content.
WHOIS data is unavailable, likely due to privacy protection.
No direct contact emails or phone numbers found; contact is via form.
Social media links to official Biogen accounts present.
No security.txt or vulnerability disclosure page found.
No explicit security policy or incident response information found.
Technical notes
Notes
The website is built on Adobe Experience Manager CMS, using modern JavaScript libraries including jQuery 3.6.4 and Video.js for media content. Google Tag Manager and Google Analytics are integrated for marketing and analytics purposes, with Cookiebot managing cookie consent. The site is mobile optimized with responsive design and good SEO practices including meta tags and Open Graph data. Performance is moderate, with video content and multiple scripts potentially impacting load times. No hosting provider details were identified from the HTML content. Overall, the technical implementation is solid but could benefit from enhanced security headers and accessibility improvements.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with biibcolombia.co. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review biibcolombia.co.